Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketodex vs Opioid Anaesthesia in Cleft Palate Repair
NCT05402189Phase 1Unknown
- Sponsor
- Ain Shams University
- Start
- Feb 2022
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of ketamine and dexmedetomidine in cleft palate (2 arms), sponsored by Ain Shams University. Primary endpoint: postoperative respiratory depression at 4 months. Status: unknown.
02
Drugs
ketaminedexmedetomidine
03
Conditions
cleft palate
Beyond the preview
Go deeper on NCT05402189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05402189.